Sepsis accounts for almost 20% of global deaths annually, and the search for answers has been decades in the making. However, The Ottawa Hospital is taking a big step forward in the next phase of a world-first clinical trial using stem cells in patients with septic shock. Early results are promising, and they could lead to innovative treatment options for millions of patients, worldwide. In this episode, Dr. Lauralyn McIntyre, an intensive care unit physician, and senior scientist, talks about moving the needle forward on sepsis research. (27:27)